Lunai Bioworks' subsidiary BioSymetrics and BrainStorm Therapeutics announced a strategic collaboration to discover and develop new neurological disease therapies using AI, human brain organoids, and in vivo validation. Supported by a LouLou Foundation grant, the partnership aims to create high-confidence drug targets for diseases like Parkinson's and rare genetic epilepsies, improving translational success and accelerating pharmaceutical partnerships. The collaboration integrates computational analysis with biological models to generate development-ready programs and expand into additional neurological conditions.
Auddia Inc. announced a 12-month partnership between its AI-driven Discovr Radio platform and Beatcave, Canada's leading independent music community. Discovr Radio becomes Beatcave's official membership partner, offering independent artists guarantee...
Heineken N.V. has repurchased a total of 3,192,296 shares under the second €750 million tranche of its €1.5 billion share buyback program, spending €219.6 million as of May 29, 2026. The shares were bought both on the exchange and from Heineken Holdi...
Uber, Autobrains, and NVIDIA announced plans to launch a robotaxi program in Munich using Autobrains’ AI and NVIDIA’s Level 4 autonomous driving platform, pending regulatory approval. This partnership aims to scale autonomous ride-hailing across mult...
Netcompany Group A/S is actively executing its share buyback programme initiated in February 2026, aiming to repurchase up to 3,250,000 shares or DKK 750 million to optimize its capital structure and fulfill share-based incentive obligations. From Ma...
The global smartphone market is projected to grow from $609.29 billion in 2026 to $739.23 billion by 2031, with a CAGR of 3.94%. Growth is fueled by increasing adoption of 5G devices, AI-powered features, premium upgrades, and innovations like foldab...
